NDC 0378-9671-64 - Ipratropium Bromide and Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9671
- Requested NDC
- 0378-9671-64
- Package NDCs from labels
- 0378-9671-31, 0378-9671-93, 0378-9671-64, 0378-9671-30, 0378-9671-60
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2018-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2018-12-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9671-30 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 CARTON | SOLUTION | 1 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 POUCH | SOLUTION | 1 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 2 in 1 CARTON | SOLUTION | 2 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-93 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 CARTON | SOLUTION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9671-30 | ML - Milliliter | 0378-9671 | fecf8d7a-ca63-4086-a192-cfe09593da7f | 1 | 2016-03-04 |
| 0378-9671-31 | ML - Milliliter | 0378-9671 | 441e8202-3014-467f-839f-1cb56dd1ff5a | 1 | 2015-05-05 |
| 0378-9671-58 | ML - Milliliter | 0378-9671 | e0ed7cbb-725f-41b4-98a8-8e4fbac96aa5 | 1 | 2013-10-17 |
| 0378-9671-60 | ML - Milliliter | 0378-9671 | ac7fec3f-8285-492f-b246-26b74402bbb7 | 1 | 2016-04-04 |
| 0378-9671-91 | ML - Milliliter | 0378-9671 | 32a69a83-77f5-460b-ac59-cdb791096167 | 1 | 2014-04-03 |
| 0378-9671-93 | ML - Milliliter | 0378-9671 | f9a81245-211d-421f-9a2b-9b034708627c | 1 | 2013-07-02 |
| 0378-9671-98 | ML - Milliliter | 0378-9671 | d5fa01b8-04ef-4d82-bc9d-1bc4f51852f7 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albuterol Sulfate | ACTIVE INGREDIENT | 021SEF3731 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium Bromide | ACTIVE INGREDIENT | J697UZ2A9J | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Albuterol | ACTIVE MOIETY | QF8SVZ843E | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium | ACTIVE MOIETY | GR88G0I6UL | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | 574824f3-51cc-4b94-9c10-e3204d8b19f8 | 2025-11-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | ASCLEMED USA INC. | 8ea40065-4f59-434f-9ea1-7ef006fde66e | 2025-11-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 056e145b-87aa-4009-a7ab-2ac0bd086eb0 | 2025-11-06 | Warnings, Adverse reactions | 021SEF3731 |
| Atrovent HFA | IPRATROPIUM BROMIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 170e98ef-5560-4068-be7d-e649068eb884 | 2025-11-05 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals, Inc. | 2c3f975c-dbd8-0362-e063-6394a90a16dd | 2025-10-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 4120061a-dbae-8918-e063-6394a90afbf2 | 2025-10-14 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 081b7bbb-6692-4512-b135-863b73bf30a5 | 2025-10-13 | Warnings, Adverse reactions | 021SEF3731 |
| AIRSUPRA | ALBUTEROL SULFATE AND BUDESONIDE | AstraZeneca Pharmaceuticals LP | e60aa9f9-5139-44df-b886-ebddc3c7eb13 | 2025-09-18 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulate HFA | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 825975b1-a4a9-78ca-e053-2a91aa0a3948 | 2025-09-02 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratroprium Bromide | IPRATROPRIUM BROMIDE | Oceanside Pharmaceuticals | 40e37c2f-a2c0-419b-8451-1aa0458bc420 | 2025-08-06 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Oceanside Pharmaceuticals | b1a5e41a-9100-41d5-a7d0-2e763ad5efb6 | 2025-08-06 | Warnings, Adverse reactions | J697UZ2A9J |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | QUAGEN PHARMACEUTICALS LLC | 99a490cc-e41d-436b-9cf3-8facb7ac714f | 2025-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 99782bc8-56d9-41f8-935e-0d0de27f0c34 | 2025-05-19 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 1c72fd84-7dbc-45d0-ab88-fb4221ce369f | 2025-05-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 264e2145-c7d4-4f4f-aa5b-9fe48a7c5b47 | 2025-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Bryant Ranch Prepack | 601a18ed-d66e-498f-a804-f1a3330827d4 | 2025-04-21 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ae35ec1f-526a-49bf-8262-c50e40190d1f | 2025-04-08 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Nephron Pharmaceuticals Corporation | db8095db-d1fd-4099-9fb1-d1ad4e284976 | 2025-04-08 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | a6545fbe-b0a6-41ae-8bb6-91af38410f56 | 2025-04-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Chartwell RX, LLC | 560df50c-e2c4-459f-9d89-bf7e6588949e | 2025-03-28 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.